A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of …

V Kasivisvanathan, F Jichi, L Klotz, A Villers… - BMJ open, 2017 - bmjopen.bmj.com
Introduction The classical pathway for the diagnosis of prostate cancer is transrectal
ultrasound-guided (TRUS) biopsy of the prostate initiated on the basis of a raised prostate …

A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of …

V Kasivisvanathan, F Jichi, L Klotz, A Villers… - BMJ …, 2017 - search.proquest.com
Methods This is a pragmatic, international, multicentre, parallel group randomised study in
which men are allocated in a 1: 1 ratio to an MPMRI or TRUS biopsy pathway. This study will …

A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of …

V Kasivisvanathan, F Jichi, L Klotz, A Villers, SS Taneja… - BMJ Open, 2017 - europepmc.org
Methods This is a pragmatic, international, multicentre, parallel group randomised study in
which men are allocated in a 1: 1 ratio to an MPMRI or TRUS biopsy pathway. This study will …

[PDF][PDF] Veeru Kasivisvanathan, Fatima Jichi, 3 Laurence Klotz, 4 Arnauld Villers, 5 Samir S Taneja, 6 Shonit Punwani, 7, 8 Alex Freeman, 9 Mark Emberton

CM Moore - scienceopen.com
Introduction The classical pathway for the diagnosis of prostate cancer is transrectal
ultrasound-guided (TRUS) biopsy of the prostate initiated on the basis of a raised prostate …

A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of …

V Kasivisvanathan, F Jichi, L Klotz, A Villers… - BMJ open, 2017 - nyuscholars.nyu.edu
Introduction The classical pathway for the diagnosis of prostate cancer is transrectal
ultrasound-guided (TRUS) biopsy of the prostate initiated on the basis of a raised prostate …

A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of …

V Kasivisvanathan, F Jichi, L Klotz, A Villers… - BMJ …, 2017 - discovery.ucl.ac.uk
INTRODUCTION: The classical pathway for the diagnosis of prostate cancer is transrectal
ultrasound-guided (TRUS) biopsy of the prostate initiated on the basis of a raised prostate …

A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of …

V Kasivisvanathan, F Jichi, L Klotz, A Villers… - BMJ …, 2017 - pubmed.ncbi.nlm.nih.gov
Introduction The classical pathway for the diagnosis of prostate cancer is transrectal
ultrasound-guided (TRUS) biopsy of the prostate initiated on the basis of a raised prostate …

A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of …

V Kasivisvanathan, F Jichi, L Klotz, A Villers, SS Taneja… - BMJ Open, 2017 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Introduction</jats: title>< jats: p> The classical pathway for the
diagnosis of prostate cancer is transrectal ultrasound-guided (TRUS) biopsy of the prostate …

[HTML][HTML] A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the …

V Kasivisvanathan, F Jichi, L Klotz, A Villers… - BMJ Open, 2017 - ncbi.nlm.nih.gov
Methods This is a pragmatic, international, multicentre, parallel group randomised study in
which men are allocated in a 1: 1 ratio to an MPMRI or TRUS biopsy pathway. This study will …

A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of …

V Kasivisvanathan, F Jichi, L Klotz, A Villers, SS Taneja… - BMJ Open, 2017 - europepmc.org
Methods This is a pragmatic, international, multicentre, parallel group randomised study in
which men are allocated in a 1: 1 ratio to an MPMRI or TRUS biopsy pathway. This study will …